Intelligence Platform

Patents

Browse 812 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9828435

Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4

VACCINEX, INC. · Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9821049

Method of conferring a protective immune response to Norovirus

Takeda Vaccines, Inc. · Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9814771

Live attenuated classical swine fever vaccine based in genetic manipulation of a putative

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9801934

Parenteral norovirus vaccine formulations

Takeda Vaccines, Inc. · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9795665

Attenuated live vaccine for Crimean-Congo hemorrhagic fever virus and Erve virus

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9795662

Vaccine comprising AMA1 and RON2

granted patent

US 9795661

TH1/TH2 polarizing vaccines

United States of America as represented by the Secretary of the Air Force · Granted Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9790271

Methods for increasing immunoglobulin A levels

VACCINEX, INC. · Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9783787

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of den

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9783579

Compositions and methods for dengue virus chimeric constructs in vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9770504

Generating peptoid vaccines

The Board of Regents of the University of Texas System · Granted Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9758591

Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

The Regents of the University of California · Granted Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9750793

Multifunctional oral vaccine based on chromosome recombineering

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9713638

Compositions and methods for rapid immunization against dengue virus

Takeda Vaccines, Inc. · Granted Tue Jul 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9713637

Bacillus anthracis HtrA-defective-derived vaccines

State of Israel, Prime Minister's Office, Israel Insitute For Biological Research · Granted Tue Jul 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9707289

Biochemically stabilized HIV-1 ENV trimer vaccine

NATIONAL INSTITUTES OF HEALTH (NIH), THE UNITED STATES OF AMERICA DEPT. OF HEALTH AND HUMAN SERVICES (DHHS). · Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9701718

Adenovirus serotype 26 and serotype 35 filovirus vaccines

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9675684

Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndro

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9676840

Anti-CD100 neutralizing antibodies and methods of using the same

VACCINEX, INC. · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9675550

Methods for inducing an immune response via buccal and/or sublingual administration of a v

The Board of Regents of the University of Texas System · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9669091

Vaccines having an antigen and interleukin-23 as an adjuvant

Inovio Pharmaceuticals, Inc. · Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9624475

Genetically stable live attenuated respiratory syncytial virus vaccine and its production

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9616115

Purified plasmodium and vaccine compositions

Sanaria Inc. · Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9603922

Modulation of NKT cell activity with antigen-loaded CD1d molecules

VACCINEX, INC. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted